The global bioconjugation market is set for strong growth as pharmaceutical and biotechnology companies increasingly adopt advanced conjugation technologies for targeted drug delivery, diagnostics, imaging, and precision medicine. According to recent market analysis, the global bioconjugation market size was valued at USD 5.08 billion in 2025 and is projected to grow from USD 5.65 billion in 2026 to USD 13.15 billion by 2034, registering a CAGR of 11.15% during the forecast period from 2026 to 2034.

Click Here to Access the Comprehensive Report:https://straitsresearch.com/re....port/bioconjugation-